Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-24-021 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support milestone-driven projects focused on developing and utilizing novel predictive models, assays, tools, and/or platforms based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens: carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Pseudomonas aeruginosa. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 1, 2024 Category: Research Source Type: funding
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics and related countermeasures against antibiotic resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae, or Candida auris. Applications must include a Product Development Strategy attachment. Substantive investment by industrial participants is highly encouraged. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 5, 2022 Category: Research Source Type: funding
Partnerships for the Development of Vaccines and Immunoprophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)
Funding Opportunity RFA-AI-17-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on discovery, establishment of proof-of-concept for, and/or preclinical development of, lead candidate vaccines or immunoprophylactics that target multiple antimicrobial-resistant Gram-negative bacterial pathogens prevalent in nosocomial infections: carbapenem-resistant Enterobacteriaceae (CRE), multidrug-resistant (MDR) Acinetobacter and MDR Pseudomonas aeruginosa. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2017 Category: Research Source Type: funding
Partnerships for the Development of Vaccines and Immunophrophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)
Funding Opportunity RFA-AI-17-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on discovery, establishment of proof-of-concept for, and/or preclinical development of, lead candidate vaccines or immunoprophylactics that target multiple antimicrobial-resistant Gram-negative bacterial pathogens prevalent in nosocomial infections: carbapenem-resistant Enterobacteriaceae (CRE), multidrug-resistant (MDR) Acinetobacter and MDR Pseudomonas aeruginosa. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2017 Category: Research Source Type: funding
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01)
Funding Opportunity ID: 290136 Opportunity Number: RFA-AI-16-081 Opportunity Title: Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.85593.856Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNati...
Source: Grants.gov - November 17, 2016 Category: Research Tags: Health Source Type: funding
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01)
Funding Opportunity RFA-AI-16-081 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on developing and utilizing novel predictive assays, models and/or research tools based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens: carbapenem-resistant Enterobacteriaceae (CRE), MDR Acinetobacter and/or MDR Pseudomonas aeruginosa. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 16, 2016 Category: Research Source Type: funding
Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01)
Funding Opportunity Number: RFA-AI-14-019 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with...
Source: Grants.gov - March 13, 2014 Category: Research Tags: Health Source Type: funding
Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01)
Funding Opportunity RFA-AI-14-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for projects focused on development and/or production of diagnostics that will enable rapid, sensitive, specific, culture-independent detection of high-priority antimicrobial-resistant Gram-negative bacterial pathogens. This FOA is focused on select healthcare-associated bacteria where resistance compromises effective treatment, including: Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and extra-intes...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2014 Category: Research Source Type: funding
DOD Military Infectious Diseases Applied Research Award
Funding Opportunity Number: W81XWH-14-DMRDP-MID-ARA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 30, 2013Award Ceiling: $0Expected Number of Awards: 5Creation Date: Jul 30, 2013Funding Opportunity Description: All applications MUST spe...
Source: Grants.gov - July 31, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DOD Military Infectious Diseases Applied Research Award
Funding Opportunity Number: W81XWH-14-DMRDP-MID-ARA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 30, 2013Award Ceiling: $0Expected Number of Awards: 5Creation Date: Apr 24, 2013Funding Opportunity Description: All applications MUST spe...
Source: Grants.gov - April 27, 2013 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
